Stocktoria
Medline Inc. MDLN
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-12-17
Chart by TradingView
6/9
Piotroski F — financial health
2.84
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Revenue | $28.4B | $25.5B |
| Gross profit | $7.5B | $7.0B |
| Operating income | $2.2B | $2.1B |
| Net income | $1.2B | — |
| Operating cash flow | $1.7B | $1.8B |
| Free cash flow | $1.3B | $1.4B |
| Total assets | $38.5B | $36.0B |
| Total liabilities | $19.2B | $19.5B |
| Shareholders' equity | $19.3B | — |
| Ratios | ||
| Gross margin | 26.4% | 27.3% |
| Operating margin | 7.8% | 8.4% |
| Net margin | 4.1% | — |
| FCF margin | 4.6% | 5.5% |
| Return on assets | 3.0% | — |
| Return on equity | 6.0% | — |
| Debt / equity | 0.65× | — |
| Current ratio | 4.29 | 3.39 |
| Revenue growth | 11.5% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 3,304,305 | $147.0M |
| SOROS FUND MANAGEMENT LLC | 1,286,434 | $57.2M |
| RENAISSANCE TECHNOLOGIES LLC | 143,700 | $6.4M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.84 (safe)
- Working capital / assets 0.213
- Retained earnings / assets 0.0
- EBIT / assets 0.057
- Equity / liabilities 1.005
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0002046386 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.